Solid Biosciences Files Q1 2025 10-Q
Ticker: SLDB · Form: 10-Q · Filed: May 15, 2025 · CIK: 1707502
| Field | Detail |
|---|---|
| Company | Solid Biosciences Inc. (SLDB) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, filing, stock-offering
TL;DR
Solid Biosciences Q1 2025 10-Q filed. Key financials and Feb 2025 stock offering noted.
AI Summary
Solid Biosciences Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its operating segments and various financial items, including treasury bills and accrued expenses. Key events mentioned include a February 2025 offering of common stock.
Why It Matters
This filing provides investors with an update on Solid Biosciences' financial health and operational activities for the first quarter of 2025, crucial for understanding their ongoing development in the biotechnology sector.
Risk Assessment
Risk Level: medium — Biotechnology companies often carry higher risk due to the nature of drug development and regulatory hurdles.
Key Numbers
- 20250331 — Period End Date (The 10-Q covers financial information up to this date.)
- 20250515 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Solid Biosciences Inc. (company) — Filer of the 10-Q
- 20250331 (date) — Period of report
- 20250515 (date) — Filing date
- February 2025 (date) — Date of stock offering
FAQ
What were the key financial highlights for Solid Biosciences in Q1 2025?
The filing details financial information for the period ending March 31, 2025, including operating segments and various balance sheet items, but specific dollar amounts for revenue or net income are not detailed in the provided header information.
Did Solid Biosciences conduct any stock offerings in the reported period?
Yes, the filing references a 'February 2025 Offering' of 'Common Stock' on February 19, 2025.
What is the primary business of Solid Biosciences?
Solid Biosciences Inc. is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
Where is Solid Biosciences headquartered?
The company's business address is 500 Rutherford Avenue, 3rd Floor, Charlestown, MA 02129.
What is the fiscal year end for Solid Biosciences?
The company's fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Solid Biosciences Inc. (SLDB).